The 15-minute Ebola test is six times faster than similar tests currently in use and aims to speed up the diagnosis of Ebola cases. Early detection of Ebola leads to better infection control as medical staff can identify and isolate confirmed cases of Ebola faster, and start treating patients sooner. Ultimately, a faster test could reduce Ebola transmission and mortality.
The project is supported through a joint Department for International Development (DFID) and Wellcome Trust fund for rapid health research during the Ebola outbreak. The six projects are managed by Enhancing Learning & Research for Humanitarian Assistance (ELRHA).
The trial, led by researchers at the Pasteur Institute in Dakar, Senegal, will be deployed using a ‘mobile suitcase laboratory’ which is designed for low-resource settings. The portable laboratory includes a solar panel, a power pack and a results reader which is the size of a small laptop.
The reagents used in the test are available as dried pellets, which are ‘cold-chain-independent’, meaning that they can be used and transported at room temperature. Similarly to the tests currently in use, the new test detects the genetic material of the virus. The pilot trial will test whether the reagents are safe and effective to use with Ebola patients’ blood and saliva samples…
Virology Training Lead – Novel and Dangerous Pathogens Training Group
Public Health England, Novel and Dangerous Pathogens Training
January 2013 – Present (1 year 11 months)PHE – Porton Down
Note: Novel and emerging would seem to be euphemisms for NEW!
“I have examined in detail the literature on isolation and Ems [EM: electron microscope pictures] of both Ebola and Marburg viruses. I have not found any convincing evidence that Ebola virus (and for that matter Marburg) has been isolated from humans. There is certainly no confirmatory evidence of human isolation.”